A Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Patients With Specific Gene Defects in the Melanocortin-4 Receptor Pathway

checkorphan
Learn more about:
Pro-opiomelanocortin Deficiency
Related Clinical Trial
A Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Patients With Specific Gene Defects in the Melanocortin-4 Receptor Pathway Setmelanotide for the Treatment of Early-Onset POMC Deficiency Obesity

Recruitment Information

Administrative Informations